A Disruptive Approach to Alzheimer's & Other Diseases

Learn about us

OUR MISSION

To develop a first-in-class approach

for treating Alzheimer’s disease,

comprising diagnostic and therapeutic

strategies, both based on a novel biological

mechanism

 

Neuro-Bio is a privately owned biotech, with a focus on neurodegenerative diseases. We have discovered a novel molecule – T14 which is toxic in the adult brain and a key driver of neurodegeneration.

 

We are developing a pre-symptomatic biomarker and drug based on this mechanism.

 

OUR VALIDATION 

 

Neuro-Bio are proud to announce our paper published May 2024 has received over 4,000 views! 

“Evidence for a novel neuronal mechanism driving Alzheimer’s disease, upstream of amyloid”

 

The nice thing about teamwork is that you always have others on your side.

At Neuro-Bio, we focus on teamwork, collaboration and achieving success together!

 

Our Collaborators

 


NeuroBio logo

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from Neuro-Bio

You have Successfully Subscribed!